Incorporation of zolpidem and methoxyphenamine into white hair strands after single administrations: Influence of hair pigmentation on drug incorporation
-
Add time:07/22/2019 Source:sciencedirect.com
In order to investigate the influence of pigmentation on the incorporation of drugs into hair, time-course changes in drug distribution along non-pigmented (white) hairs as well as pigmented (black) hairs plucked from the same subject was observed following single administrations of two basic drugs with different properties, zolpidem and methoxyphenamine. These drugs in 1-mm sections of single hair specimens were each determined by a liquid chromatography–tandem mass spectrometric procedure. During the early stage (12–36 h) after intake, for black hairs, both drugs were detected over the entire area of hair root (4–5 mm in length), in which notable concentration of these drugs in the hair bulb (0–1-mm segment from the bottom of hair root, Region 1) and lower concentrations in the upper dermis zone (1–2-mm to 3–4-mm or to 4–5-mm segments, Region 2) were commonly observed. Meanwhile, for white hairs, high drug concentrations in Region 1 as detected in black hairs were not observed although only small amounts of these drugs were detected over Region 2. Subsequent time-course changes in the concentration of drugs in hair demonstrated that the drugs once incorporated into white hair via Region 2 decreased gradually over the period from 24 h to 35 days after intake, but those of black hairs remained almost unchanged. These findings revealed here suggest that hair pigments have two important roles in the distribution of drugs: (1) incorporation of drugs into hair via Region 1, and (2) retention of already incorporated drugs in the hair tissue. These findings would be useful for discussing individual drug-use history based on hair analysis in the forensic fields.
We also recommend Trading Suppliers and Manufacturers of Zolpidem 6-Carboxylic Acid (cas 109461-15-6). Pls Click Website Link as below: cas 109461-15-6 suppliers
Prev:CYP3A4 and CYP2C19 genetic polymorphisms and zolpidem metabolism in the Chinese Han population: A pilot study
Next:Simultaneous analysis of zolpidem and its metabolite in whole blood and oral fluid samples by SPE-LC/MS for clinical and forensic purposes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Simultaneous analysis of zolpidem and its metabolite in whole blood and oral fluid samples by SPE-LC/MS for clinical and forensic purposes07/23/2019
- CYP3A4 and CYP2C19 genetic polymorphisms and zolpidem metabolism in the Chinese Han population: A pilot study07/20/2019
- The correlation between concentrations of zolpidem and benzodiazepines in segmental hair samples and use patterns07/21/2019
- A rapid and accurate UPLC/MS/MS method for the simultaneous determination of zolpidem and its main metabolites in biological fluids and its application in a forensic context07/19/2019
- Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In Silico07/18/2019
- Fatal zolpidem poisoning due to its intravenous self-injection: Postmortem distribution/redistribution of zolpidem and its predominant metabolite zolpidem phenyl-4-carboxylic acid in body fluids and solid tissues in an autopsy case07/17/2019


